The Utility of Telemedicine in the Management of Migraine

Migraine Headaches Clinical Trial

Official title:

The Utility of Telemedicine in the Management of Migraine: A Pilot Study :MK0974-071-00

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01706003
• Other study ID #: MK0974-071-00
• Secondary ID: MERCK
• Status: Completed
• Start date: October 2012
• Est. completion date: October 2018

Study information

• Verified date: September 2019
• Source: University of Texas Southwestern Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits.

Description:

After obtaining informed consent, patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits. All subjects will complete a MIDAS questionnaire and allodynia questionnaire at their initial visit. Follow-up visits will be scheduled at 4-6 weeks, 3, 6, 9 and 12 months. In-person follow-up visits will be conducted in the standard fashion of the current physician's practice, with the initial intake conducted by an ophthalmic technician or resident, followed by the physician visit. Telemedicine visits will be conducted by the physician and recorded. Similar information will be gathered in both groups including: current medications, interim medical and headache history (including visits to the ED or hospitalizations for headache), description of headache, response to treatment (including adverse reactions), allergies, blood pressure and weight. Subjects randomized to telemedicine will be asked to have their blood pressure and weight measured within 5 days of their telemedicine session at a location convenient to them. We will record the length of each visit. Subjects in the in-person group, will be queried about travel time, and the total amount of time for the visit, and any activities missed to attend the visit. We will also ask about other costs associated with attending the office visit, such as child care.

At the one-year follow-up visit, subjects will complete the MIDAS, allodynia questionnaire, Modified Group Health Association of America's Consumer Satisfaction scale, and have the opportunity to express their views on the aspect of care received in a semi-structured interview. The follow-up questionnaires may be completed on line (telemedicine group, optional for in-person group) or on paper (in-person group). Headache diaries will be provided on line or may be done on paper, a smartphone, or a computer program of the subject's choosing.

All subjects will be able to access the physician by telephone, using MyChart, or with additional non-study visits as needed.

Subjects will be responsible for the cost of the medications, treatments prescribed, and laboratory monitoring needed for their condition.

Support staff will be available to help set up the video system for subjects assigned to the telemedicine group who are in need of assistance.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: October 2018
• Est. primary completion date: October 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:• Ages 18 - 89 years

• Diagnosis of migraine with or without aura, menstrual migraine, hemiplegic migraine

• Able to provide informed consent

• Able, in the opinion of the investigator, to reliably perform all aspects of the study

• Ownership of or access to a computer and high speed internet

Criteria for Exclusion of Subjects:

• Age less than 18 years

• Headache type is not migraine

• No ownership or access to a computer or high speed internet

• Unfamiliar with basic computer operations or uncomfortable using a computer

• Unwilling to participate

• Unable to read English (because of assessment tools)

• History of another medical, psychiatric, social or behavioral problem that, in the opinion of the investigator, makes it unlikely that they will be able to complete the study activities. Questions regarding mood and anxiety are asked of all patients as part of their initial evaluation for headache.

Related Conditions & MeSH terms

• Headache
• Migraine Disorders
• Migraine Headaches

Locations

Country	Name	City	State
United States	Universit of Texas Southwestern	Dallas	Texas

Sponsors (2)

Lead Sponsor	Collaborator
University of Texas Southwestern Medical Center	Merck Sharp & Dohme Corp.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice	Percentage of completed scheduled study visits for each group.	One Year